🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety and immune response to GlaxoSmithKline ...
Status
Completed
Location
GSK Investigational Site
Start Date
2002-11
Trial ID
NCT00109330
Treatments Being Tested
That is a double-blind randomized trial with parallel control to demonstrat...
Status
Completed
Location
Hospital Regional Materno Infantil de alta especialidad, Secretaria de Salud de Nuevo Leon
Start Date
2011-09
Trial ID
NCT01445743
Treatments Being Tested
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested
This study will look at your body's response to the new immunizations. We w...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2007-07-10
Trial ID
NCT00505063
The purpose of this study is to assess the effect of nipocalimab treatment ...
Status
Completed
Location
CRS Clinical Research Services Berlin GmbH
Start Date
2023-04-12
Trial ID
NCT05827874
Treatments Being Tested
Currently, there are two types of vaccines available against pertussis (who...
Status
Unknown
Location
Sukuta Health Centre
Start Date
2019-01-23
Trial ID
NCT03606096
The purpose of this study is to evaluate the safety of Sabin Inactivated Po...
Status
Completed
Location
Gaoan Center for Disease Control and Prevention
Start Date
2022-06-13
Trial ID
NCT05432141
Treatments Being Tested
A prospective, randomized open-label clinical trial will be conducted from ...
Status
Completed
Location
Centers for Disease Control and Prevention
Start Date
2018-07-17
Trial ID
NCT03530124
Eligible,healthy infants who have finished the 3-dose-schedule of sIPV+DTaP...
Status
Unknown
Location
Hebei Provincial Center for Disease Control and Prevention
Start Date
2020-11-11
Trial ID
NCT04636827
Treatments Being Tested